Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2122721rdf:typepubmed:Citationlld:pubmed
pubmed-article:2122721lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C1524119lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C0442043lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C0053572lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:2122721lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:2122721pubmed:issue11lld:pubmed
pubmed-article:2122721pubmed:dateCreated1990-12-7lld:pubmed
pubmed-article:2122721pubmed:abstractTextWe studied the temporal profile of urinary NH2-terminal big gastrin immunoreactivity (NT G-34-IR) excretion in order to evaluate the dynamics of gastrin secretion. The temporal profile of urinary NT G-34-IR excretion in normal subjects represented three peaks corresponding to each meal. In contrast, the profile in antrectomized patients and patients under total parenteral nutrition (TPN) represented a flat pattern. Urinary NT G-34-IR excretions during fasting 2-h periods in antrectomized patients and TPN patients were about one-sixth and one-third, respectively, of basal NT G-34-IR excretion in normal subjects (53.1 +/- 13.9 pmol/h). Total urinary NT G-34-IR excretion during 24 h both in antrectomized patients (220 +/- 35 pmol/24 h) and TPN patients (390 +/- 68 pmol/24 h) was also significantly lower than in normal subjects (1985 +/- 403 pmol/24 h). The present study showed that the main source of urinary NT G-34-IR is the gastric antrum, that the main factor fluctuating its excretion is food intake, and that long-term TPN reduces basal gastrin secretion. Urinary NT G-34-IR would be a useful indicator for total gastrin secretion.lld:pubmed
pubmed-article:2122721pubmed:languageenglld:pubmed
pubmed-article:2122721pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2122721pubmed:citationSubsetIMlld:pubmed
pubmed-article:2122721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2122721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2122721pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2122721pubmed:statusMEDLINElld:pubmed
pubmed-article:2122721pubmed:monthNovlld:pubmed
pubmed-article:2122721pubmed:issn0002-9270lld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:TaruiSSlld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:HimenoSSlld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:MiyazakiYYlld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:YasunagaYYlld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:NagaoKKlld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:ShinomuraYYlld:pubmed
pubmed-article:2122721pubmed:authorpubmed-author:HigashimotoYYlld:pubmed
pubmed-article:2122721pubmed:issnTypePrintlld:pubmed
pubmed-article:2122721pubmed:volume85lld:pubmed
pubmed-article:2122721pubmed:ownerNLMlld:pubmed
pubmed-article:2122721pubmed:authorsCompleteYlld:pubmed
pubmed-article:2122721pubmed:pagination1489-92lld:pubmed
pubmed-article:2122721pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:meshHeadingpubmed-meshheading:2122721-...lld:pubmed
pubmed-article:2122721pubmed:year1990lld:pubmed
pubmed-article:2122721pubmed:articleTitleTemporal profiles of urinary excretion of NH2-terminal big gastrin immunoreactivity in humans.lld:pubmed
pubmed-article:2122721pubmed:affiliationSecond Department of Internal Medicine, Osaka University Medical School, Japan.lld:pubmed
pubmed-article:2122721pubmed:publicationTypeJournal Articlelld:pubmed